Back to Search Start Over

Optimal ultrasonic treatment frequency and duration parameters were used to detect the pathogenic bacteria of orthopedic implant-associated infection by ultrasonic oscillation.

Authors :
Xian, Chunxing
Liu, Yanwu
Zhou, Lei
Ding, Ting
Chen, Jingdi
Wang, Taoran
Gao, Jiakai
Hao, Xiaotian
Bi, Long
Source :
Journal of Infection & Chemotherapy (Elsevier Inc.). Dec2024, Vol. 30 Issue 12, p1237-1243. 7p.
Publication Year :
2024

Abstract

The most accurate method for detecting the pathogen of orthopedic implant-associated infections (OIAIs) is sonication fluid (SF). However, the frequency and duration of ultrasound significantly influence the number and activity of microorganisms. Currently, there is no consensus on the selection of these two parameters. Through this study, the choice of these two parameters is clarified. We established five ultrasonic groups (40kHz/10min, 40kHz/5min, 40 kHz/1min, 20kHz/5min, and 10kHz/5min) based on previous literature. OIAIs models were then developed and applied to ultrasound group treatment. Subsequently, we evaluated the efficiency of bacteria removal by conducting SEM and crystal violet staining. The number of live bacteria in the SF was determined using plate colony count and live/dead bacteria staining. The results of crystal violet staining revealed that both the 40kHz/5min group and the 40kHz/10min group exhibited a significantly higher bacterial clearance rate compared to the other groups. However, there was no significant difference between the two groups. Additionally, the results of plate colony count and fluorescence staining of live and dead bacteria indicated that the number of live bacteria in the 40kHz/5min SF group was significantly higher than in the other groups. 40kHz/5min ultrasound is the most beneficial for the detection of pathogenic bacteria on the surface of orthopedic implants. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
1341321X
Volume :
30
Issue :
12
Database :
Academic Search Index
Journal :
Journal of Infection & Chemotherapy (Elsevier Inc.)
Publication Type :
Academic Journal
Accession number :
180155007
Full Text :
https://doi.org/10.1016/j.jiac.2024.05.013